Shares of Incyte (INCY +4.4%) rally with the help of a reiteration by analysts at Jefferies of a Buy rating and the announcement that the firm is presenting positive results for its ruxolitinib treatment for various cancers at a Hematology conference today.
Shares of Incyte (INCY +4.4%) rally with the help of a reiteration by analysts at Jefferies of a...
Recommended For You
About INCY Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| INCY | - | - |
| Incyte Corporation | ||